EUR 23.72
(0.08%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 539.64 Million EUR | 10.71% |
2022 | 487.45 Million EUR | 52.1% |
2021 | 320.47 Million EUR | 14.31% |
2020 | 280.36 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 629.72 Million EUR | -0.19% |
2024 Q2 | 630.92 Million EUR | 21.29% |
2024 Q1 | 520.18 Million EUR | -3.61% |
2023 Q4 | 539.64 Million EUR | 7.51% |
2023 FY | 539.64 Million EUR | 10.71% |
2023 Q3 | 501.93 Million EUR | 0.0% |
2023 Q2 | - EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2022 FY | 487.45 Million EUR | 52.1% |
2022 Q4 | 487.45 Million EUR | 0.0% |
2021 FY | 320.47 Million EUR | 14.31% |
2020 FY | 280.36 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Carl Zeiss Meditec AG | 860.02 Million EUR | 37.252% |
Fielmann Aktiengesellschaft | 1.2 Billion EUR | 55.385% |
Gerresheimer AG | 1.95 Billion EUR | 72.421% |
Sartorius Aktiengesellschaft | 6.99 Billion EUR | 92.288% |
Sartorius Aktiengesellschaft | 6.99 Billion EUR | 92.288% |